热门资讯> 正文
诺维里斯健康科学首席执行官约书亚·巴奇辞职
2026-03-11 04:15
- HEALTH SCIENCES ACQUISITIONS CORP 2(HSAQ) 0
- MYDECINE INNOVATIONS GROUP INC(MYCOF) 0
- Strategy(MSTR) 0
- Noveris Health Sciences (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) on Tuesday said that Joshua Bartch has resigned as Director, President and CEO of the company.
- The company appointed Jason Birmingham, its Chief Strategy Officer since February 2, 2026, to assume the three roles previously held by Bartch.
- Noveris thanked Bartch for his service and wished him well in his future endeavors.
- MYCOF closed -40.05% at $0.1308.
- Source: Press Release
More on Mydecine Innovations Group
- Financial information for Mydecine Innovations Group
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
